GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21550
Submission : 2008-04-18
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25091
Submission : 2011-06-20
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30027
Submission : 2015-11-10
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 510
Submission : 1963-01-03
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25091
Submission : 2011-06-20
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21550
Submission : 2008-04-18
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30027
Submission : 2015-11-10
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 510
Submission : 1963-01-03
Status : Active
Type : IV
EXCIPIENTS BY APPLICATIONS
Application : Direct Compression
Excipient Details : Peo-NF is a pharmaceutical excipient that acts as a diluent in osmotic tablets and sustained-release tablets.
Application : Controlled & Modified Release
Excipient Details : Peo-NF is a pharmaceutical excipient that acts as a diluent in osmotic tablets and sustained-release tablets.
Application : Fillers, Diluents & Binders
Excipient Details : Peo-NF is a pharmaceutical excipient that acts as a diluent in osmotic tablets and sustained-release tablets.
https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-seqens-evonik-make-strategic-moves-new-guidelines-deal-with-contamination
MARKET PLACE
Reply
17 Jan 2024
Reply
10 Oct 2023
Reply
24 Dec 2019
REF. STANDARDS & IMPURITIES
LOOKING FOR A SUPPLIER?